Ocular Therapeutix SG&A Expense (TTM) Insights

Ocular Therapeutix Inc (OCUL)

6.65 -0.02 (-0.30%) USD | NASDAQ | Jul 08, 16:00

6.65 0.00 (0.00%) After-Hours: 18:48

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	78.86M
December 31, 2023	74.49M
September 30, 2023	76.10M
June 30, 2023	76.92M
March 31, 2023	75.49M
December 31, 2022	72.14M
September 30, 2022	69.94M
June 30, 2022	68.87M
March 31, 2022	67.94M
December 31, 2021	67.07M
September 30, 2021	63.79M
June 30, 2021	58.61M
March 31, 2021	52.92M
December 31, 2020	49.47M
September 30, 2020	48.78M
June 30, 2020	49.23M
March 31, 2020	50.21M
December 31, 2019	46.61M
September 30, 2019	41.33M
June 30, 2019	33.91M
March 31, 2019	26.94M

Date	Value
December 31, 2018	23.73M
September 30, 2018	21.50M
June 30, 2018	23.45M
March 31, 2018	28.69M
December 31, 2017	32.51M
September 30, 2017	32.86M
June 30, 2017	29.30M
March 31, 2017	23.21M
December 31, 2016	17.70M
September 30, 2016	15.91M
June 30, 2016	15.24M
March 31, 2016	14.05M
December 31, 2015	13.02M
September 30, 2015	12.16M
June 30, 2015	11.31M
March 31, 2015	9.774M
December 31, 2014	8.895M
September 30, 2014	6.598M
June 30, 2014	4.844M
March 31, 2014	3.698M
December 31, 2013	2.386M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

41.33M

Minimum

Sep 2019

78.86M

Maximum

Mar 2024

62.57M

Average

67.07M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks